Word

LIBIQE

Status

Dead

Status Code

606

Status Date

Monday, February 14, 2022

Serial Number

88771083

Mark Type

4000

Filing Date

Thursday, January 23, 2020

Published for Opposition

Tuesday, May 19, 2020

Abandoned Date

Monday, February 14, 2022

Trademark Owner History

Eli Lilly and Company - Owner At Publication

Classifications

5 Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, headaches, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, neurodegenerative diseases and disorders, neurological disorders, obesity, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis; Diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases and of oncology and of pain

Trademark Events

Feb 14, 2022

Abandonment Notice E-Mailed - No Use Statement Filed

Feb 14, 2022

Abandonment - No Use Statement Filed

Jun 15, 2021

Notice Of Approval Of Extension Request E-Mailed

Jun 11, 2021

Extension 2 Granted

Jun 11, 2021

Extension 2 Filed

Jun 11, 2021

Teas Extension Received

Dec 22, 2020

Notice Of Approval Of Extension Request E-Mailed

Dec 21, 2020

Extension 1 Granted

Dec 2, 2020

Extension 1 Filed

Dec 21, 2020

Case Assigned To Intent To Use Paralegal

Dec 2, 2020

Teas Extension Received

Jul 14, 2020

Noa E-Mailed - Sou Required From Applicant

May 19, 2020

Official Gazette Publication Confirmation E-Mailed

May 19, 2020

Published For Opposition

Apr 29, 2020

Notification Of Notice Of Publication E-Mailed

Apr 13, 2020

Approved For Pub - Principal Register

Apr 13, 2020

Assigned To Examiner

Jan 28, 2020

New Application Office Supplied Data Entered In Tram

Jan 27, 2020

New Application Entered In Tram